| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population … A Cassini, LD Högberg, D Plachouras, A Quattrocchi, A Hoxha, ... The Lancet infectious diseases 19 (1), 56-66, 2019 | 2944 | 2019 |
| Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ... The Lancet infectious diseases 13 (9), 785-796, 2013 | 1885 | 2013 |
| Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions LS Tzouvelekis, A Markogiannakis, M Psichogiou, PT Tassios, GL Daikos Clinical microbiology reviews 25 (4), 682-707, 2012 | 1477 | 2012 |
| International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical … BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019 | 723 | 2019 |
| Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems GL Daikos, S Tsaousi, LS Tzouvelekis, I Anyfantis, M Psichogiou, ... Antimicrobial agents and chemotherapy 58 (4), 2322-2328, 2014 | 717 | 2014 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 579 | 2008 |
| An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection MA Fischl, RB Uttamchandani, GL Daikos, RB Poblete, JN Moreno, ... Annals of internal medicine 117 (3), 177-183, 1992 | 542 | 1992 |
| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 529 | 2018 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 489 | 2017 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 467 | 2022 |
| Treating infections caused by carbapenemase-producing Enterobacteriaceae LS Tzouvelekis, A Markogiannakis, E Piperaki, M Souli, GL Daikos Clinical Microbiology and Infection 20 (9), 862-872, 2014 | 408 | 2014 |
| Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ... Infectious diseases and therapy 7 (4), 439-455, 2018 | 389 | 2018 |
| Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ... Clinical Microbiology and Infection 16 (2), 102-111, 2010 | 363 | 2010 |
| Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli MA Fischl, GL Daikos, RB Uttamchandani, RB Poblete, JN Moreno, ... Annals of internal medicine 117 (3), 184-190, 1992 | 351 | 1992 |
| Carbapenemase-producing Klebsiella pneumoniae:(when) might we still consider treating with carbapenems? GL Daikos, A Markogiannakis Clinical Microbiology and Infection 17 (8), 1135-1141, 2011 | 329 | 2011 |
| Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections GL Daikos, P Petrikkos, M Psichogiou, C Kosmidis, E Vryonis, A Skoutelis, ... Antimicrobial agents and chemotherapy 53 (5), 1868-1873, 2009 | 287 | 2009 |
| Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from … AP Magiorakos, K Burns, J Rodríguez Baño, M Borg, G Daikos, U Dumpis, ... Antimicrobial Resistance & Infection Control 6, 1-17, 2017 | 284 | 2017 |
| Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria M Akova, GL Daikos, L Tzouvelekis, Y Carmeli Clinical Microbiology and Infection 18 (5), 439-448, 2012 | 278 | 2012 |
| Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome RB Uttamchandani, GL Daikos, RR Reyes, MA Fischl, GM Dickinson, ... Clinical infectious diseases 18 (3), 348-353, 1994 | 260 | 1994 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 257 | 2008 |
